Quantity versus quality of LDL cholesterol in patients with familial hypercholesterolemia - Which is more important?

Clinica Chimica Acta

Volumn 314, Issue 1-2, 2001, Pages 167-173

  Paiker, Janice E ^a   Raal, Frederick J ^a   Waisberg, Rita ^a   Buthelezi, E Pilani ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Atherosclerosis; Familial Hypercholesterolemia; Fatty acids; LDL particle size; Lipid oxidation; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; FATTY ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; COPPER; LIPID;

ADOLESCENT; ADULT; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LIPID COMPOSITION; MALE; OXIDATION; PARTICLE SIZE; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; BLOOD; CHEMISTRY; GENETICS; HYPERCHOLESTEROLEMIA; OXIDATION REDUCTION REACTION; QUALITY CONTROL;

ADULT; COPPER; FATTY ACIDS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPIDS; LIPOPROTEINS, LDL CHOLESTEROL; MALE; OXIDATION-REDUCTION; PARTICLE SIZE; QUALITY CONTROL; VITAMIN E;

EID: 0035162219     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00688-X     Document Type: Article

References (35)

1. The pathogenesis of atherosclerosis: A perspective for the 1990s
2. The oxidation hypothesis of atherosclerosis
3. Oxidative modification of LDL and atherogenesis
4. Lipoprotein oxidation and lipoprotein-induced cytotoxicity
5. Atherosclerosis, basic mechanisms: Oxidation, inflammation and genetics
6. Cell mediated immunity in atherosclerosis
7. Lipoproteins in normal and atherosclerotic aorta
8. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
9. Susceptibility of low density lipoprotein to oxidation and coronary atherosclerosis in man
10. Oxidative status of lipoprotein in coronary disease patients
11. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk
12. Susceptibility of small, dense, low density lipoproteins to oxidative modification in subjects with atherogenic lipoprotein phenotype, pattern B
13. Low density lipoprotein subclass patterns and risk of myocardial infarction
14. The molecular basis and diagnosis of familial hypercholesterolemia in South African Afrikaners
15. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge
16. Continuous monitoring of in vitro oxidation of human low density lipoprotein
17. Identification of multiple subclasses of plasma low density lipoproteins in normal humans
18. Improved direct determination of alpha- and gamma-tocopherols in plasma and platelets by liquid chromatography with flourescence detection
19. Single vertical density gradient ultracentrifugation
20. Rapid method for measuring copper induced LDL oxidation
21. Determination of fatty acids in the main lipoprotein classes by capillary chromatography: BF3/Methanol transesterification of lyophilized samples instead of Folch extraction gives higher yields
22. Beyond cholesterol: Modifications low-density lipoprotein that increase its atherogenicity
23. Susceptibility of low density lipoprotein to oxidation in familial hypercholesterolemia
24. Diminished susceptibility to in vitro oxidation of low-density lipoprotein in hypercholesteromia: Key role of alpha-tocopherol content
25. LDL oxidation and the extent of coronary atherosclerosis
26. Extent of a antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants
27. Characterization of lipoprotein in a kindred with familial hypercholesterolemia
28. Differential low density lipoprotein hydrated density distribution in female and male patients with familial hypercholesterolemia
29. The role of alpha-tocopherol as a peroxyl scavenger in human low density lipoprotein
30. Antioxidants and atherosclerotic heart disease
31. Effects of antioxidants on oxidative modification of LDL
32. Effect of dietary supplementation with alpha-tocopherol in the oxidative modification of low density lipoprotein
33. Tocopherol mediated peroxidation (TMP) of lipoproteins: Implications for vitamin E as a potential antiatherogenic supplement
34. Co-existence of oxidised lipids and alpha-tocopherol in all lipoprotein fractions isolated from advanced human atherosclerotic plaques
35. The fatty acid composition of serum low density lipoprotein and lymphocyte cholesterol esters in children with heterozygous familial hypercholesterolemia